4.8 Article

MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation

期刊

CELL REPORTS
卷 23, 期 13, 页码 3701-3709

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2018.05.058

关键词

-

资金

  1. NIH [HL-130253, HL-138426, HD-087351, DK-099653, AR-067294, P41-EB015908, R37-HL034557]
  2. American Heart Association [16POST31100009]
  3. Fondation Leducq Networks of Excellence
  4. Robert A. Welch Foundation [1-0025]
  5. National Heart, Lung, and Blood Institute, NIH
  6. Ruth L. Kirschstein National Research Service Award (NRSA) [F32HL129674]

向作者/读者索取更多资源

Micropeptide regulator of beta-oxidation (MOXI) is a conserved muscle-enriched protein encoded by an RNA transcript misannotated as non-coding. MOXI localizes to the inner mitochondria! membrane where it associates with the mitochondria! trifunctional protein, an enzyme complex that plays a critical role in fatty acid 13-oxidation. Isolated heart and skeletal muscle mitochondria from MOXI knockout mice exhibit a diminished ability to metabolize fatty acids, while transgenic MOXI overexpression leads to enhanced 13-oxidation. Additionally, hearts from MOXI knockout mice preferentially oxidize carbohydrates over fatty acids in an isolated perfused heart system compared to wild-type (WT) animals. MOXI knockout mice also exhibit a profound reduction in exercise capacity, highlighting the role of MOXI in metabolic control. The functional characterization of MOXI provides insight into the regulation of mitochondria! metabolism and energy homeostasis and underscores the regulatory potential of additional micropeptides that have yet to be identified.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据